Novel de novo CLCN7 mutation in refractory osteopetrosis-related osteomyelitis: A case report and multidisciplinary therapeutic dilemmas | Canada Hyperbarics
Case Report J Stomatol Oral Maxillofac Surg 2025

Novel de novo CLCN7 mutation in refractory osteopetrosis-related osteomyelitis: A case report and multidisciplinary therapeutic dilemmas

Zhang Y, Jin Q, Xu M, Xu J, Zhong Y, Li C, et al. — J Stomatol Oral Maxillofac Surg, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on a 57-year-old man with a rare genetic bone disorder called osteopetrosis, complicated by a severe jaw infection, and his treatment.

What They Found

A 57-year-old male with osteopetrosis and a novel CLCN7 gene mutation developed severe, persistent jaw osteomyelitis. Despite a comprehensive treatment plan including partial splenic artery embolization, antibiotics (cefuroxime and ornidazole), hyperbaric oxygen therapy, and pleural drainage, the infection continued due to dead bone.

What This Means for Canadian Patients

For Canadian patients with rare genetic bone disorders like osteopetrosis complicated by severe infections, this case highlights the challenges in treatment. It suggests that even with a multidisciplinary approach including HBOT, complex bone infections in these conditions can be very difficult to resolve.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a single case report, the findings from this patient cannot be applied broadly to all individuals with osteopetrosis or similar infections.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 41421595
Year Published 2025
Journal J Stomatol Oral Maxillofac Surg

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.